|
CTCF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.90370000000095E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.183100E-03 |
| Normal-vs-Stage2 |
7.000000E-04 |
| Normal-vs-Stage3 |
1.57939999967383E-07 |
| Normal-vs-Stage4 |
4.6567000000497E-07 |
| Stage1-vs-Stage2 |
1.465250E-01 |
| Stage1-vs-Stage3 |
3.298800E-03 |
| Stage1-vs-Stage4 |
6.338900E-03 |
| Stage2-vs-Stage3 |
5.249000E-01 |
| Stage2-vs-Stage4 |
4.879800E-01 |
| Stage3-vs-Stage4 |
8.654600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.70082999999543E-05 |
| Normal-vs-AfricanAmerican |
1.96646999999217E-05 |
| Normal-vs-Asian |
6.541200E-01 |
| Caucasian-vs-AfricanAmerican |
1.303240E-01 |
| Caucasian-vs-Asian |
2.732000E-01 |
| AfricanAmerican-vs-Asian |
9.483600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.5897000007561E-08 |
| Normal-vs-Female |
5.980900E-03 |
| Male-vs-Female |
1.104420E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.717800E-03 |
| Normal-vs-Age(41-60Yrs) |
7.769600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.05120000004622E-06 |
| Normal-vs-Age(81-100Yrs) |
1.350500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.912200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.542400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.118200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.576400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.361900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.575600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.454200E-01 |
| Normal-vs-Grade 2 |
1.109600E-02 |
| Normal-vs-Grade 3 |
2.31919999871266E-08 |
| Normal-vs-Grade 4 |
1.41079999904647E-08 |
| Grade 1-vs-Grade 2 |
1.845230E-01 |
| Grade 1-vs-Grade 3 |
3.423400E-03 |
| Grade 1-vs-Grade 4 |
8.210300E-04 |
| Grade 2-vs-Grade 3 |
9.99790000000278E-05 |
| Grade 2-vs-Grade 4 |
4.76230000001632E-06 |
| Grade 3-vs-Grade 4 |
5.049600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.245830E-01 |
| Normal-vs-ccB subtype |
6.7905000511459E-09 |
| ccA subtype-vs-ccB subtype |
5.58090018643043E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.36929999999358E-05 |
| Normal-vs-N1 |
1.378570E-03 |
| N0-vs-N1 |
1.974550E-01 |
|
|
